ClinicalTrials.gov
ClinicalTrials.gov Menu

Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01343095
Recruitment Status : Terminated (Loss of study staff)
First Posted : April 27, 2011
Results First Posted : December 20, 2017
Last Update Posted : January 23, 2018
Sponsor:
Information provided by (Responsible Party):
Wake Forest University Health Sciences ( Wake Forest University )

Brief Summary:
This study seeks to examine the effects of overnight noise reduction in critically ill patients who are receiving mechanical ventilation. The investigators will randomly place subjects into one of three groups: 1) usual care 2) overnight earplugs 3) overnight earplugs and noise-canceling headphones. The investigators will monitor for safety, and will measure the amount of delirium experienced by subjects, record the amount of sedating and painkilling medicines required, and measure sleep quality during the study, among other information. The investigators will also measure noise levels experienced by patients in each group. The investigators predict that the use of overnight noise reduction will be safe and will reduce the amount of delirium by improving the quality of sleep in critically ill patients.

Condition or disease Intervention/treatment Phase
Delirium Sleep Fragmentation Device: Foam Earplugs Device: Noise Canceling Headphones Not Applicable

Detailed Description:

Delirium is an acute confusional state defined by fluctuating mental status, inattention, and either disorganized thinking or an altered level of consciousness. Acute delirium is an increasingly recognized problem in intensive care units (ICUs) in the US and worldwide. ICU Delirium has been estimated to occur in as many as 50 to 80 percent of ICU patients. Delirium in the ICU has been associated with worsened clinical outcomes such as prolonged hospitalization and death [1-4]. Although noise has been shown to negatively influence sleep in the ICU, and sleep disturbance is a recognized contributor to ICU delirium[1-2, 4], there is no well-established link between ICU noise levels and the development of ICU delirium. Optimal strategies for the prevention and treatment of ICU delirium are yet to be defined, and this study will focus on a novel noise-reduction approach which has potential to impact both prevention and treatment [5-8]. Findings will be generalizable to other tertiary care medical intensive care units caring for adult patients.

Objectives Our multidisciplinary team will evaluate the safety and feasibility of direct noise reduction in the Wake Forest University Baptist Medical Center (WFUBMC) Medical Intensive Care Unit (MICU), and any effect on the incidence of ICU delirium.

Methods and Measures Design

  • Forty-five (45) patients receiving mechanical ventilation will be randomized to receive either passive direct noise reduction (earplugs), both passive and active direct noise reduction (earplugs and noise-canceling headphones), or no direct noise reduction (usual practice).
  • Ambient noise levels and the reduction in noise accomplished by direct noise reduction will be measured according to standardized audiometric techniques.
  • Sleep structure, including amount of recovery sleep, will be measured over one night according to standardized polysomnographic (sleep study) techniques
  • The incidence of delirium will be assessed as well as multiple other endpoints including but not limited to amount of psychoactive medication prescribed and amount of physical restraints required.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: A Randomized Controlled Trial of Direct Noise Reduction in the ICU Using Overnight Application of In-ear Earplugs or In-ear Earplugs Plus Noise-Canceling Headphones to Reduce the Incidence and Duration of ICU Delirium
Study Start Date : May 2011
Actual Primary Completion Date : December 2014
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Delirium Noise
U.S. FDA Resources

Arm Intervention/treatment
No Intervention: Usual Care
Usual Care between 10pm-6am
Active Comparator: Earplugs
Application of foam earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Device: Foam Earplugs
Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Active Comparator: Earplugs and Headphones
Foam Earplugs and Noise canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Device: Foam Earplugs
Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Device: Noise Canceling Headphones
Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.



Primary Outcome Measures :
  1. Days Free of Delirium or Coma [ Time Frame: During the Study Period (Study Days 0-7 while patients were in ICU) ]

Secondary Outcome Measures :
  1. Noise Attenuation [ Time Frame: Overnight (10pm-6am) on study day 2 or 3. ]
    The reduction in noise experienced by the subject when using the study intervention.

  2. Sleep Efficiency and Architecture [ Time Frame: Overnight (10pm-6am) on study day 2 or 3 ]
    Staging of sleep with efficiency determined as a ratio of total sleep time/total study time.

  3. Amount of Sedative Use (Midazolam and Lorazepam) [ Time Frame: During the Study Period (Study Days 0-7) ]
  4. Amount of Analgesic Use [ Time Frame: During the Study Period (Study Days 0-7) ]
    Mean of analgesic daily use

  5. Amount of Sedative Use (Propofol and Demedetomidine ) [ Time Frame: During the Study Period (Study Days 0-7) ]
    Mean of sedative daily use (Propofol and Demedetomidine )



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients who are admitted to our MICU for at least 24 hours with at least 72 hours' additional expected stay in ICU, and who are mechanically ventilated

Exclusion Criteria:

  • severe to profound hearing loss
  • baseline use of hearing aids
  • eardrum perforation
  • severe cerumen impaction
  • head or oromaxillofacial trauma
  • external ventricular drain or intracranial pressure monitoring devices
  • comatose patients who are deemed by their attending physician as unlikely to awaken within 72 hours
  • patient status as comfort-measures only
  • any other contraindication to the use of earplugs or headphones

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01343095


Locations
United States, North Carolina
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157
Sponsors and Collaborators
Wake Forest University
Investigators
Study Director: Matthew C Miles, MD Wake Forest University Health Sciences

Responsible Party: Wake Forest University
ClinicalTrials.gov Identifier: NCT01343095     History of Changes
Other Study ID Numbers: IRB00013140
First Posted: April 27, 2011    Key Record Dates
Results First Posted: December 20, 2017
Last Update Posted: January 23, 2018
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: de-identified data was shared with another investigator as part of a review and meta-analysis

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes

Keywords provided by Wake Forest University Health Sciences ( Wake Forest University ):
ICU Delirium
Delirium
Sleep Quality
Sleep Efficiency
ICU Noise
Noise Reduction
Earplugs
Noise Canceling Headphones

Additional relevant MeSH terms:
Delirium
Sleep Deprivation
Confusion
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neurocognitive Disorders
Mental Disorders
Dyssomnias
Sleep Wake Disorders